Home Blog Page 14

Nigerian Army College Of Nursing, Yaba, Lagos State Begins Sale Of 2024/2025 Admission Forms

Application For Admission Into

ND/HND Nursing Programme For 2024/2025 Admission Session.

ADMISSION IS OPEN TO MILITARY, PARA-MILITARY PERSONNEL, AND CIVILIANS

Admission Requirements

  • Candidates must possess a minimum of five (5) credits in WAEC, GCE, NECO, or NABTEB results which must include English Language, Mathematics, Biology, Physics, and Chemistry at not more than two (2) sittings.
  • Candidates must be between the ages of 16-26 years by October, 2024.
  • Candidates must be a Nigerian by birth.
  • Candidates must have written JAMB, and scored a minimum of 120.

Programme Duration:

Four (4) Years for ND/HND Nursing Programme.

Purchase Of Application Forms:

Application can be obtained from the registrar’s office on payment of non-refundable fee of N20,550 Naira Only.

Return Of Application Forms:

Completed application forms must be returned to the College with photocopies of credentials a week before the selection interview.

Date Of Selection Interview

11th – 16th November, 2024.

NOTE: CANDIDATES SHALL BE RESPONSIBLE FOR THEIR ACCOMMODATIONS, TRANSPORT, AND FEEDING THROUGHOUT THE PERIOD OF SELECTION INTERVIEW/TEST.

For Further Enquiries:

07039397753

Nigeria Airforce School Of Medical Science And Aviation Medicine Begins 2024/2025 Admission Forms

Application For Admission Into ND/HND Nursing Programme For 2024/2025 Academic Session.

Admission is opened to Military, Para-Military Personnel and Civilians.

Admission Requirements:

  • Candidates must possess a maximum of 5 (five) credits in WAEC/ GCE/ O Level/ NABTEB or NECO results which must include English Language, Mathematics, Biology, Physics, and Chemistry at not more than two (2) sittings.
  • Candidates must be between the ages of 16-28 years by October, 2024.
  • Candidates must be Nigerian by birth.
  • Candidates must have written JAMB 2024 and scored a minimum of 120.

Admission Requirements:

Four (4) years for ND/HND Nursing Programme.

Purchase Of Application Form:

Application form can be obtained from Registrar’s Office on payment of a non-refundable fee of N25,200 only.

Purchase Of Application Form:

Completed Application Form must be returned to the College of with photocopies of your credentials a week before the Selection Interview.

Date Of Selection Interview/Test:

9th-18th September, 2024.

All Candidates Are To Make Application Through The School Secretary.

NOTE: Candidates Shall Be Responsible For Their Accommodation, Transports, And Feeding Throughout The Period Of Selection Interview/Test

For Further Enquiries, Call or send Mail:

07087185958

Jos University Teaching Hospital Opens For 2024 Job Application

0

Applications are invited from suitably qualified candidates for the following positions in Jos University Teaching Hospital:

  • Residency Training
  • Consultants
  • Radiographers
  • Nursing Superintendents
  • Nursing Officers
  • Scientific Officers (Medical Physics)
  • Health Information Management
  • Technicians

A RESIDENCY TRAINING IN THE FOLLOWING DEPARTMENTS:

  • Anaesthesia
  • Chemical Pathology
  • Community Medicine
  • Oral and Maxillofacial Surgery
  • Preventive Dentistry
  • Restorative Dentistry
  • Child Oral Health
  • Oral Diagnostics
  • Family Medicine
  • Haematology
  • Histopathology
  • Medical Microbiology
  • Internal Medicine
  • Obstetrics & Gynaecology
  • Ophthalmology
  • Orthopaedics & Trauma
  • Otorhinolaryngology (ENT)
  • Paediatrics
  • Psychiatry
  • Radiology
  • Surgery
  • Accident and Emergency

Requirements:

Applicants seeking admission into the Residency Training Programme must possess the fallowing:

  • Evidence of graduation from any accredited medical school (MB&S).
  • Evidence of passing primary examination of either the National or West African Postgraduate Medical College in the candidate’s chosen field of specialization.
  • Evidence of full registration with the Medical and Dental Council of Nigeria.
  • Evidence of current annual practicing license, and
  • Evidence of NYSC discharge certificate or exemption as the case may be.


SALARY: CONMESS 3.

CONSULTANTS

  • Radio-Oncologists
  • Child Oral Heath


REQUIREMENTS:

  • Candidates must possess Fellowship of National Post Graduate Medical College of Nigeria or Fellowship of West African Post- Graduate Medical College.
  • Candidates should have current practicing license by the Medical and Dental Council of Nigeria and NYSC discharge or exemption certificate

SALARY: CONMESS 5.

RADIOGRAPHERS

REQUIREMENTS:

  • Candidates must possess Bachelor’s degree in Radiography.
  • Candidates must possess license from Nigerian Radiographers Registration Board {NRRB) to practice Radiography.
  • NYSC discharge or exemption certificate

SALARY: CONHESS 9.

NURSING SUPERINTENDENTS

REQUIREMENTS:

  • Candidates must possess the Nursing & Midwifery (NRN & NRM) qualification and duly registered with the Nursing and Midwife Council of Nigeria

(NMCN) SALARY: CONHESS 7.

NURSING OFFICERS

REQUIREMENTS:

  • Candidates must possess B.Sc. Nursing, one-year Post-Graduation Internship.
  • NYSC discharge or exemption certificate.
  • Nursing & Midwifery Council registered and License to Practice with cognate post-graduation experience.

SALARY: CONHESS 9.

SCIENTIFIC OFFICERS (MEDICAL PHYSICISTS)

REQUIREMENTS:

  • Candidates must possess a Bachelor’s degree {or its equivalent) in Medical Physics and appropriate Sciences.
  • NYSC discharge or exemption certificate

SALARY: CONHESS 7.

HEALTH INFORMATION MANAGEMENT TECHNICIANS

REQUIREMENTS:

  • Candidates must possess B.Sc./HND in Health Information Management, must be registered with Health Records Officers Registration Board of Nigeria (HRORBN)

SALARY: CONHESS 7.

METHOD OF APPLICATION

Applicants should submit one (1) copy of application attaching photocopies of relevant credentials and Curriculum Vitae, indicating the following information:

Full names
Age
Sex
Place and date of birth
Permanent Home address
Nationality
State of origin
Local Government Area
Contact address
Phone number(s)
E-mail address
Marital status
Institutions attended with dates
Academic qualifications obtained with dates
Extracurricular activities
Names, addresses and phone numbers of three referees

SUBMISSION OF APPLICATION

All applications should be submitted in a sealed envelope and marked “Application for mail address Residency Training in….” (State the Department) or “Application for the post of ” (State the Cadre) i.e. according to the post you are applying for) at the top left hand comer of the envelope and addressed to:

Application for mail address Residency Training in….” (State the Department) or “Application for the post of ” (State the Cadre) i.e. according to the post you are applying for) at the top left hand comer of the envelope and addressed to:

The Director of Administration

Jos University Teaching Hospital

P.M. B. 2076

Jos.

NOTE:

The closing date for submission of applications is on or before 3:30pm of Wednesday, 11“ September, 2024.
Only shortlisted candidates shall be invited for interview.
Previous applications submitted are NOT valid.
Applicants must strictly adhere to the content of this advert.
Thank you.

Signed

Mrs. Roseline A. Sani

FOR: CHIEF MEDICAL DIRECTOR

NOTE ON HEPATOBILIARY SYSTEM FOR NURSING AND MEDICAL STUDENTS

HEPATOBILIARY SYSTEM: Clinical Pathology Overview


UNIT OUTLINE

Gall Bladder

  1. Introduction to Gall Bladder and Gall Stones – 1 hour
  2. Cholecystitis – 1 hour

Pancreas

  1. Disorders of the Pancreas – 1 hour

Liver

  1. Introduction, Manifestations, and Investigations – 2 hours
  2. Circulatory Disturbances – 1 hour
  3. Viral Hepatitis – 2 hours
  4. Non-Viral Hepatitis – 2 hours
  5. Alcoholic Liver Disease and Liver Cirrhosis – 1 hour
  6. Metabolic Liver Disease and Tumours – 1 hour

Lesson 1: Gall Bladder – Introduction and Gall Stones

Learning Outcomes:

  1. Describe the structure and functions of the organs of the hepatobiliary system
  2. Describe the pathology of gall stones
  3. Investigate gall stones

Introduction – Hepatobiliary Anatomy and Physiology

  • Components: Liver, pancreas, gallbladder, bile ducts

Gall Bladder Anatomy

  • Gross Anatomy:
  • Saclike, pear-shaped, 9 cm long
  • Storage capacity: 35-100 ml
  • Consists of fundus, body, neck
  • Biliary Ducts and Tracts:
  • Two hepatic ducts from liver unite to form common hepatic duct
  • Joined by cystic duct to form common bile duct (CBD)
  • CBD enters duodenum; 70% cases join with pancreatic duct (Ampulla of Vater)
  • Histology:
  • Mucosal, smooth muscle, perivascular, serosal layers

Functions:

  1. Concentrates bile
  2. Emulsifies fats in intestines
  3. Facilitates cholesterol excretion

Bile Acids:

  • Primary: Cholic acid, chenodeoxycholic acid
  • Secondary: Deoxycholate, lithocholate

Pathophysiology of Gall Bladder Disorders:

  • Congenital abnormalities
  • Cholelithiasis (gall stones)
  • Cholecystitis
  • Obstruction of CBD
  • Tumours

Gall Stones (Cholelithiasis)

  • Formation: Cholesterol, bile pigments, calcium salts
  • Risk Factors: 4F’s – Fat, Female, Fertile, Forty/Fifty
  • Pathogenesis: Supersaturation, nucleation, microstone, gallstone

Lesson 2: Cholecystitis

Learning Outcomes:

  1. Describe the pathophysiology and pathology of cholecystitis
  2. Investigate cholecystitis

Introduction

  • Inflammation of gall bladder (acute, chronic, acute on chronic)

Acute Cholecystitis

  • Mechanisms:
  • Acute calculous: Obstruction, distension, inflammation
  • Acute acalculous: Ischemia, severe conditions
  • Pathology:
  • Gross: Distended, tense, serosal congestion, lumen filled with pus
  • Microscopy: Oedema, congestion, neutrophil infiltration, necrosis, ischemia

Key Points for Study:

  • Understand the anatomy and physiology of the hepatobiliary system.
  • Familiarize with the types, formation, and risk factors of gall stones.
  • Recognize the clinical features and complications of gall bladder disorders.
  • Comprehend the pathophysiology of cholecystitis and its differentiation between calculous and acalculous types.
  • Be prepared to investigate and diagnose hepatobiliary conditions through appropriate tests and imaging.

HEPATOBILIARY SYSTEM

Clinical Features

  • Severe abdominal pain in the upper abdomen with features of peritoneal irritation (muscle guarding and hyperesthesia)
  • Tender gall bladder (Murphy’s sign – right hypochondrial tenderness and rigidity, worse on inspiration)
  • Possible palpable gall bladder, slight jaundice, fever, leukocytosis with neutrophilia, restlessness, pallor, sweating, and vomiting

Investigations

  1. Plain abdominal radiograph (X-ray) for gallstones
  2. Cholecystography
  3. Ultrasonography for gallstones
  4. Radionuclide biliary scintigraphy
  5. Raised serum amylase
  6. Full haemogram showing moderate leukocytosis
  7. Possible bilirubinuria

Differential Diagnosis

  1. Perforated peptic ulcer
  2. Acute pancreatitis
  3. Perforated cancer
  4. Liver abscess
  5. Retroperitoneal appendicitis
  6. Right-sided pleurisy
  7. Right basal pneumonia
  8. Myocardial infarction
  9. Renal colic

Complications

  • Perforation, peritonitis, biliary fistula (cholecystenteric fistula), recurrent attacks, adhesions, gall bladder gangrene, cholangitis, empyema, mucocele

CHRONIC CHOLECYSTITIS

Overview

  • The most common gall bladder disease associated with gallstones
  • May be insidious in onset or follow repeated attacks of acute cholecystitis

Aetiology & Pathogenesis

  • Associated with gallstones and repeated acute cholecystitis

Pathology

Gross (Macroscopic) Appearance

  • Generally contracted (small) but may be normal or enlarged; shrunken with marked fibrous thickening (Courvoisier’s sign – palpable gall bladder); thickened walls with an irregular lining, mucosal folds (intact, thickened or flattened and atrophied); lumen containing stones and fluid (clear, turbid, or purulent)

Microscopic Appearance (Histology)

  • Thickened and congested mucosa; Rokitansky-Aschoff sinuses (gland-like structures formed as a result of penetration of epithelial down growths through the muscular layer); chronic inflammatory cells (lymphocytes, plasma cells, and macrophages); fibrosis

Complications

  • Acute exacerbations (acute cholecystitis), pancreatitis, cholecyst-enteric fistula, gallstone ileus, ca gall bladder, mucocele, pyemia

CHOLEDOCHOLITHIASIS AND ASCENDING CHOLANGITIS

Overview

  • Choledocholithiasis: Presence of stones within the biliary tree
  • Cholangitis: Bacterial infection of the bile ducts

Clinical Features

  • Fever, chills, abdominal pain, and jaundice accompanied by acute inflammation of the wall of the bile ducts

Pathogenesis

  • Obstruction of bile flow mainly due to stones in the biliary tract
  • Common bacteria include enteric Gram-negative aerobes (E. coli, Klebsiella, Clostridium, Bacteroides, Enterobacter) and Group D streptococci

Investigations

  • As acute cholecystitis

DISORDERS OF THE PANCREAS

Learning Outcomes

  1. Outline the anatomy and physiology of the pancreas
  2. Outline the developmental abnormalities of the pancreas
  3. Describe the pathology of pancreatitis
  4. Investigate pancreatitis

Anatomy

Position

  • Lies transverse within the posterior deep abdominal cavity across the upper lumbar vertebrae
  • Head tucked into the loop of the duodenum with the tail reaching the hilus of the spleen
  • Intimate contact with organs (stomach, duodenum, transverse colon, spleen, kidneys, and suprarenal glands) and blood vessels (aorta, vena cava, hepatic artery, portal vein, and splenic vessels)

Gross Anatomy

  • The name pancreas is derived from the Greek word “ankreas” meaning “all flesh”
  • Soft, lobulated, glandular organ with both exocrine and endocrine functions
  • Divided into four parts – head, neck, body, and tail weighing 2-3 gm (neonates), 7 gm (first year), 40 gm (15 years), 70-150 gm in adults, and length 15-25 cm

Histology

  • Secretory units are small glands called acini that join to form lobules and eventually lobes
  • The acinar cells synthesize the pancreatic enzymes

Physiology

Exocrine

  • Pancreatic juices contain enzymes, water, and electrolytes. There are at least 22 enzymes including proteolytic enzymes (elastase, amylases), trypsin, chymotrypsin, lipase, phospholipase, carboxypeptidase, cholesteristerase, ribonuclease, and deoxyribonuclease

Endocrine

  • Islets of Langerhans secrete hormones
  • Major cell types: Beta cells (70%) secrete insulin, alpha cells (20%) secrete glucagon, delta cells (5-10%) produce somatostatin (suppresses both insulin and glucagon release), pancreatic polypeptide cells (1-2%)
  • Minor cell types: D1 cells elaborate vasoactive intestinal peptide (VIP) inducing glycogenolysis and hyperglycemia, enterochromaffin cells synthesize serotonin

CONDITION OF THE PANCREAS

Overview

  • Conditions include benign tumors, pancreatic cancer, cystic fibrosis, diabetes (covered in endocrine pathology), exocrine pancreatic insufficiency, hemosuccus pancreaticus, and pancreatitis (acute and chronic)

DEVELOPMENTAL ANOMALIES

Overview

  • Congenital anomalies include agenesis, hypoplasias, annular pancreas, and aberrant pancreas

Cystic Fibrosis

  • Hereditary autosomal recessive disorder characterized by viscid secretions in all exocrine glands (mucoviscidosis) and increased concentration of electrolytes in eccrine organs
  • Secretions obstruct passages resulting in fibrosis, affecting multiple organs and systems (pancreatic insufficiency, intestinal obstruction, steatorrhea, malnutrition, hepatic cirrhosis, and respiratory complications)

Pathology

Macroscopy

  • Visible cysts, fat replacement of pancreatic tissues

Microscopy

  • Architecture of pancreatic parenchyma maintained, increased interlobular fibrosis, atrophy of acinar ducts, rarely inflammation, fat necrosis, intact Islets of Langerhans

PANCREATITIS

Introduction

  • Pancreatitis is inflammation of the pancreas, which can be acute or chronic
  • Diagnostic criteria include abdominal pain characteristic of acute pancreatitis, serum amylase and/or lipase ≥3 times the upper limit of normal, and characteristic findings of acute pancreatitis on CT scan

Classification

  • Classified according to Marseilles, Cambridge, Revised Marseilles, Atlanta International Symposium (IAS), etiological, or pathological basis
  • IAS (1992) clinical-based classification reflects on acute pancreatitis: mild acute pancreatitis and severe acute pancreatitis

ACUTE PANCREATITIS

Definition

  • Sudden inflammation of the pancreas associated with necrosis of intrahepatic fat and acini

Predisposing Factors

  1. Biliary tract disease (gallstones, cholecystitis)
  2. Excess alcohol intake
  3. Abdominal surgery on the biliary tract, pancreas, and stomach
  4. Trauma (abdominal injuries, stab wounds)
  5. Metabolic disorders (hyperparathyroidism, hypervitaminosis D)
  6. Infections (mumps, hepatitis, Coxsackie’s virus)
  7. Drugs (thiazide diuretics, paracetamol overdose, high steroid doses)

Aetiology

  • Alcoholism and gallstones are the most important causes of acute pancreatitis

Common Causes – Mnemonic “I GET SMASHED”

  • I: Idiopathic
  • G: Gallstones
  • E: Ethanol (alcohol)
  • T: Trauma
  • S: Steroids
  • M: Mumps (paramyxovirus), other viruses (Epstein-Barr virus, Cytomegalovirus)
  • A: Autoimmune disease (Polyarteritis nodosa, Systemic lupus erythematosus)
  • S: Scorpion sting (e.g., Tityus trinitatis), snake bites
  • H: Hypercalcemia, hyperlipidemia/hypertriglyceridemia, hypothermia
  • E: ERCP (Endoscopic Retrograde Cholangio-Pancreatography)
  • D: Drugs (SAND – steroids & sulfonamides, azathioprine, NSAIDS, diuretics such as furosemide and thiazides, & didanosine), duodenal ulcers

Pathogenesis

  • Occurs in three phases:
  1. First phase: Premature activation of trypsin
  2. Second phase: Activated trypsin causes inflammation within the pancreas
  3. Third phase: Inflammation spreads to other organs (e.g., lungs – ARDS), mediated by cytokines and other inflammatory mediators

Pathophysiology

  • Destruction of the pancreas due to liberation and activation of pancreatic enzymes

Enzyme Production

  • Proteases such as trypsin and chymotrypsin cause proteolysis
  • Lipases and phospholipids degrade lipids and membrane phospholipids
  • Elastases destroy the elastic tissue of blood vessels

Activation of Pan

creatic Enzymes

  • Activation is normally under the control of trypsin, and when disrupted, enzymes can autodigest the pancreas

Pathology

  • Macroscopy: Swollen, edematous gland with fat necrosis and areas of hemorrhage
  • Microscopy: Edema, fat necrosis, hemorrhage, neutrophilic infiltration, and necrotic pancreatic tissue

Clinical Features

  • Sudden severe epigastric pain radiating to the back
  • Nausea and vomiting
  • Abdominal distension
  • Fever and tachycardia
  • Hypotension and shock in severe cases
  • Cullen’s sign: periumbilical ecchymosis
  • Grey-Turner’s sign: flank ecchymosis

Investigations

  • Serum amylase and lipase (elevated)
  • Liver function tests
  • Complete blood count
  • Serum calcium
  • Ultrasound and CT scan

Complications

  • Systemic: ARDS, renal failure, metabolic disturbances
  • Local: Pancreatic necrosis, abscess, pseudocyst

CHRONIC PANCREATITIS

Definition

  • Prolonged inflammation of the pancreas resulting in irreversible structural damage and loss of function

Aetiology

  • Chronic alcoholism, hereditary, idiopathic, tropical pancreatitis

Pathogenesis

  • Chronic inflammation leads to fibrosis, calcification, and atrophy

Pathology

  • Macroscopy: Firm gland with calcifications and fibrosis
  • Microscopy: Loss of acinar cells, fibrosis, and chronic inflammatory cell infiltrate

Clinical Features

  • Recurrent episodes of abdominal pain
  • Steatorrhea and malabsorption
  • Diabetes mellitus

Investigations

  • Serum amylase and lipase (may be normal)
  • Fecal elastase
  • Imaging: Ultrasound, CT scan, MRI

Complications

  • Pancreatic pseudocyst, pancreatic cancer, biliary obstruction, diabetes

This summary captures the key points about hepatobiliary and pancreatic disorders, focusing on clinical features, investigations, differential diagnosis, complications, and specific conditions such as acute and chronic pancreatitis. Let me know if there’s anything more specific you need!

School Of Post-Basic Nursing Anesthesia, Jos University Teaching Hospital Begins Sale Of 2025/2026 Admission Form

Applications are invited from suitably qualified candidates for admission into the above-mentioned Training Programme for the 2025/2026 session.

Admission Requirements:

  1. Applicant must be a registered nurse (RN) with a current practicing license.
  2. Have at least 2 years of post-qualification experience preferably in Theatre Unit.
  3. Holds West African School Certificate, Senior Secondary School Certificate, National Examination Council, or General Certificate of Education at ordinary level, with five (5) credits to include English Language, and three (3) relevant Science subjects (Biology, Physics, and Chemistry).
  4. Graduates of Nursing Science (BNSc) or Master in Nursing Science are also eligible.

Method Of Application:

Application forms are obtained from the Chairman, Medical Adversary Committee’s Office on presentation of receipt for payment of a non-refundable fee of N10,000 from the Accounts Department (RRR).

Completed application forms with a typewritten self-addressed and stamped envelope must be returned to the office of the coordinator, Nurse Anesthesia Training Programme, Jos University Teaching Hospital, latest 30th September, 2024.

Method Of Selection:

Selection of candidates for the course is on the basis of the result of the written examination or oral interview scheduled for Wednesday 9th and Thursday 10th, October 2024.

The duration of the course is 18 months with effect from April 2025 through October 2026.

For further inquires:

Contact: Coordinator, Nurse Anesthesia-JUTH, 08035570340 or HOD, Nursing Services— JUTH, 08037158368

College of Nursing Sciences, Maiduguri, Borno State Announces Date For 2024/205 Entrance Exam

0


The schedule date of aptitude test has been announced on the 15th AUGUST 2024.

TO WHOM IT MAY CONCERN

PLATEAU STATE COLLEGE OF NURSING SCIENCES, VOM ANNOUNCES DATE FOR SALES OF 2024/2025 ADMISSION FORMS

PLATEAU STATE COLLEGE OF NURSING SCIENCES

Office of the Registrar
College of Nursing Sciences, VOM

Public Announcement

Sales of Post UTME Forms into the Basic Nursing Program for the 2024/2025 Academic Session

This announcement is directed to the general public and prospective students who have written JAMB and chosen the College of Nursing Sciences, VOM and College of Nursing sciences, Jos as their first choice, scoring 170 and above that the Post UTME form for the 2024/2025 academic session is now available.

Interested candidates are expected to obtain application forms from the Academic Registry of the College of Nursing Sciences, VOM upon payment of a non-refundable fee of N5,000. Payment should be made using the Remita platform in the college bursary.

The forms will be available starting from Monday, 5th August 2024, and will close on Friday, 23rd August 2024, giving a three-week period from this announcement.

Candidates are to note that there will be no extension of the deadline for the sales of application forms.

ANNOUNCER:

Nurse Laraba Kure
Registrar

HIV and AIDS: Nursing Course Notes

Topic: Objectives

Objectives:

  • Describe the basic concepts of HIV and AIDS.
  • Appreciate global and national HIV statistics and epidemiology.
  • Explain HIV combination prevention intervention.
  • Describe HIV positive living.

Topic One: Definition of Terms

HIV (Human Immunodeficiency Virus):

  • Virus causing HIV infection and AIDS.
  • Weakens the immune system by destroying disease-fighting cells.
  • Preventable and manageable, but not curable.
  • Transmitted via body fluids (blood, breast milk, semen, vaginal secretions).
  • Not transmitted through kissing, hugging, shaking hands, sharing personal objects, food, or water.
  • Invades helper T cells (CD4+ cells) in the body.
  • No signs or symptoms in the initial stages, but still infectious.
  • Body can’t fight off infections, leading to AIDS.

AIDS (Acquired Immune Deficiency Syndrome):

  • Disease caused by a confirmed positive test for HIV.
  • Predisposes patients to multiple opportunistic infections, leading to death.

Risk Factors of HIV Infection

  • Unprotected sex (anal or vaginal).
  • Having STIs (e.g., syphilis, herpes, Chlamydia, gonorrhea, bacterial vaginosis).
  • Sharing injecting needles.
  • Receiving unsafe injections, tissue transplantation, or medical procedures involving unsterile cutting or piercing.
  • Accidental needle stick injuries (healthcare workers).
  • Mother-to-child transmission during pregnancy, birth, or breastfeeding.

HIV Prevention Key Approaches

  • Biomedical Prevention:
  • Condom use promotion and distribution.
  • Elimination of mother-to-child transmission (EMTCT).
  • Voluntary medical male circumcision (VMMC).
  • Methadone replacement therapy.
  • STI treatment.
  • Blood safety.
  • Behavioral Interventions:
  • HIV testing.
  • Behavior change communication.
  • Social/Structural Interventions:
  • Social Protection (e.g., Cash Transfers for Orphans and Vulnerable Children – CT-OVC).
  • Building resilience of women and girls.
  • Girls enrolled in secondary school.

HIV Positive Living

  • Antiretroviral (ARV) drugs control the virus and prevent transmission for healthy, long, and productive lives.
  • Antiretroviral therapy (ART) should be taken daily and right away to reduce viral load.
  • Use condoms correctly every time you have sex.
  • Choose less risky sexual behaviors.
  • Not sharing needles for drug use.
  • Pre-exposure prophylaxis (PrEP).
  • Adherence to treatment.
  • Get tested and treated for other STIs.
  • Encourage partners to get tested for HIV.

Topic Two: Modes of HIV Transmission and Key Risk Factors

Modes of Transmission:

  • Heterosexual (male-female) and homosexual (men having sex with men).
  • Non-consensual sexual exposures (assault).
  • Parenteral: transfusion of infected blood or blood products, exposure to infected blood/body fluids through contaminated sharps, IDU needle sharing or needle stick accidents, donated organs.
  • Perinatal/Vertical: transplacental, during labor/delivery, breastfeeding.
  • HIV is not transmitted by casual contact, surface contact, or insect bites.

Biological Factors Influencing HIV Transmission:

  • Disease status of the source patient (related to immunosuppression and viral load).
  • Presence of untreated STIs in the source and person at risk.
  • Circumcision status: uncircumcised men are more likely to acquire HIV than circumcised.
  • Gender differences: females are more susceptible due to genital anatomy.

Socio-economic Factors Facilitating HIV Transmission:

  • Social mobility: partners living apart.
  • Stigma and denial.
  • People in conflict: war and struggle for power.
  • Cultural factors: traditions, beliefs, and practices.
  • Gender: acceptance of men having multiple sexual partners, gender inequalities, inability of women to negotiate condom use.
  • Poverty: lack of information needed to understand and prevent HIV.
  • Drug use and alcohol consumption: impaired judgment, sharing of needles and equipment.

Key Populations (KP):

  • Groups at increased risk of HIV due to specific high-risk behaviors.
  • Include sex workers, men who have sex with men, people who inject drugs, and transgender people.
  • Should receive routine HIV testing every 3 months and retesting at least annually.

Vulnerable Populations:

  • Persons at high risk due to situations beyond their control.
  • Include widows and widowers, orphans and vulnerable children (OVCs), families and children living on the streets, young women aged 15-24 years, servicemen and women, refugees, displaced persons and migrants, people who abuse alcohol, survivors of sexual and gender-based violence.

Survivors of Sexual and Gender-Based Violence:

  • Should receive HIV testing services (HTS) at first contact.
  • Immediate referral for clinical evaluation, documentation and treatment, trauma counseling, and post-exposure prophylaxis (PEP).
  • Retesting recommended after 4 weeks, and if still negative or in a discordant relationship, retesting at 12 weeks.

Topic Three: Global HIV Statistics

Global HIV Statistics (2016):

  • People living with HIV: 36.7 million.
  • People accessing antiretroviral therapy: 19.5 million.
  • Newly infected with HIV: 1.8 million.
  • Deaths from AIDS-related illnesses: 1 million.
  • Total people infected since the epidemic began: 76.1 million.
  • Total deaths by AIDS: 35 million.

HIV/Tuberculosis (TB) Co-infection:

  • Leading cause of death among people living with HIV.
  • Around one in three AIDS-related deaths due to TB.
  • Global TB cases (2015): 10.4 million; 1.2 million among people living with HIV.
  • TB-related deaths among people living with HIV fell by 33% between 2005 and 2015.
  • 60% of TB cases among people living with HIV were not diagnosed or treated, resulting in 390,000 TB-related deaths among people living with HIV in 2015.

HIV is not transmitted by:

  • Touching/hugging.
  • Mutual masturbation, kissing, oral sex.
  • Insect bites.
  • Water, food, air.
  • Sharing toilet seats, tables, door handles, cutlery, towels.

Myths and Misconceptions of HIV and AIDS

  • Common myths and misconceptions should be addressed to improve understanding and reduce stigma.

Topic Two: The Immune System

The Immune System:

  • A system of special cells (lymphocytes, monocytes), proteins (antibodies), tissues, and organs that defend the body against foreign substances (antigens).

Antigen:

  • A foreign substance which stimulates the immune system to respond by producing antibodies.

Antibody:

  • A protein produced by lymphocytes, binding to specific antigens.

Immune System Organization:

  • The immune system is organized into innate, cellular, and humoral responses.
  • Organs involved are categorized into primary (thymus and bone marrow) and secondary (lymph nodes and spleen) lymphoid organs.

Cellular Responses to HIV Infection:

  • HIV enters the body, triggering anti-HIV antibody and cytotoxic T cell production.
  • Macrophages and dendritic cells present the virus to CD4 cells.
  • CD4 T lymphocytes are the main target for HIV attack.
  • CD8+ cytotoxic cells lyse HIV-infected cells and secrete cytokines and chemokines to inhibit virus replication.

Humoral Response to HIV:

  • Production of specific antibodies in response to HIV infection.
  • Non-neutralizing antibodies target HIV structural proteins (P17 and P24).
  • Neutralizing antibodies target gp120, CD4 binding sites, chemokine receptors, and gp41.

Combined Cellular and Humoral Response:

  • Both responses play important roles in HIV infection.
  • Cellular responses are initiated first, followed by antibody responses 4-8 weeks after infection.
  • B cells produce antibodies, but mutations in HIV glycoproteins render them ineffective.

Summary

  • HIV has become a pandemic since the first cases were identified.
  • It is a major cause of morbidity and mortality, especially in sub-Saharan Africa (SSA).
  • Multiple factors contribute to HIV transmission in society.
  • Effective prevention requires a combination of biomedical, behavioral, and social/structural interventions.